Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 (CSGALNACT1) (C-Term) Peptide
Quick Overview for Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 (CSGALNACT1) (C-Term) Peptide (ABIN8096975)
Target
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- ChGn Peptide - C-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-ChGn antibody ( ARP47435_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- CSGALNACT1 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 (CSGALNACT1))
-
Background
-
Background Information: ChGn transfers 1,4-N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of glucuronic acid (GlcUA). This protein is required for addition of the first GalNAc to the core tetrasaccharide linker and for elongation of chondroitin chains. It play an important role in chondroitin chain biosynthesis in cartilage.
Alternative Symbols: FLJ11264, beta4GalNAcT, ChGn, CSGalNAcT-1
-
Molecular Weight
- 61kDa
-
Gene ID
- 55790
-
NCBI Accession
- NP_060841
-
UniProt
- Q8TDX6
Target
-